VE‐821 is a ATR inhibitor with potent inhibitory activities on the phosphorylation of H2AX and CHK1 by ATR, and sensitizing effect on cancer cells to radiotherapy and genotoxic chemotherapeutics.66, 231, 377, 378, 379. The gene discussed is ATR; the disease is cancer.